These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 19652625)

  • 21. Non-small cell lung cancer in never smokers: a clinical entity to be identified.
    Santoro IL; Ramos RP; Franceschini J; Jamnik S; Fernandes AL
    Clinics (Sao Paulo); 2011; 66(11):1873-7. PubMed ID: 22086516
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Presentation and stage-specific outcomes of lifelong never-smokers with non-small cell lung cancer (NSCLC).
    Subramanian J; Velcheti V; Gao F; Govindan R
    J Thorac Oncol; 2007 Sep; 2(9):827-30. PubMed ID: 17805060
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of smoking status on progression-free and overall survival in non-small cell lung cancer patients receiving erlotinib or gefitinib: a meta-analysis.
    Sohn HS; Kwon JW; Shin S; Kim HS; Kim H
    J Clin Pharm Ther; 2015 Dec; 40(6):661-71. PubMed ID: 26573867
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association Between Smoking History and Overall Survival in Patients Receiving Pembrolizumab for First-Line Treatment of Advanced Non-Small Cell Lung Cancer.
    Popat S; Liu SV; Scheuer N; Gupta A; Hsu GG; Ramagopalan SV; Griesinger F; Subbiah V
    JAMA Netw Open; 2022 May; 5(5):e2214046. PubMed ID: 35612853
    [TBL] [Abstract][Full Text] [Related]  

  • 25. East meets West: ethnic differences in epidemiology and clinical behaviors of lung cancer between East Asians and Caucasians.
    Zhou W; Christiani DC
    Chin J Cancer; 2011 May; 30(5):287-92. PubMed ID: 21527061
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survival among Never-Smokers with Lung Cancer in the Cancer Care Outcomes Research and Surveillance Study.
    Clément-Duchêne C; Stock S; Xu X; Chang ET; Gomez SL; West DW; Wakelee HA; Gould MK
    Ann Am Thorac Soc; 2016 Jan; 13(1):58-66. PubMed ID: 26730864
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomized phase II trial of first-line treatment with pemetrexed-cisplatin, followed sequentially by gefitinib or pemetrexed, in East Asian, never-smoker patients with advanced non-small cell lung cancer.
    Ahn MJ; Yang JC; Liang J; Kang JH; Xiu Q; Chen YM; Blair JM; Peng G; Linn C; Orlando M
    Lung Cancer; 2012 Aug; 77(2):346-52. PubMed ID: 22534669
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic factors for survival of stage I nonsmall cell lung cancer patients : a population-based analysis of 19,702 stage I patients in the California Cancer Registry from 1989 to 2003.
    Ou SH; Zell JA; Ziogas A; Anton-Culver H
    Cancer; 2007 Oct; 110(7):1532-41. PubMed ID: 17702091
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of the benefit from gefitinib monotherapy with smoking status in Japanese patients with non-small-cell lung cancer.
    Hotta K; Kiura K; Takigawa N; Fujiwara Y; Tabata M; Ueoka H; Tanimoto M
    Lung Cancer; 2008 Nov; 62(2):236-41. PubMed ID: 18485523
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic factors in stage III non-small-cell lung cancer.
    Ademuyiwa FO; Johnson CS; White AS; Breen TE; Harvey J; Neubauer M; Hanna NH
    Clin Lung Cancer; 2007 Sep; 8(8):478-82. PubMed ID: 17922971
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Smoking status and survival in the national comprehensive cancer network non-small cell lung cancer cohort.
    Ferketich AK; Niland JC; Mamet R; Zornosa C; D'Amico TA; Ettinger DS; Kalemkerian GP; Pisters KM; Reid ME; Otterson GA
    Cancer; 2013 Feb; 119(4):847-53. PubMed ID: 23023590
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Real-World Data on Prognostic Factors for Overall Survival in EGFR Mutation-Positive Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Gefitinib.
    Yao ZH; Liao WY; Ho CC; Chen KY; Shih JY; Chen JS; Lin ZZ; Lin CC; Chih-Hsin Yang J; Yu CJ
    Oncologist; 2017 Sep; 22(9):1075-1083. PubMed ID: 28507206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Race/ethnicity and lung cancer survival in the United States: a meta-analysis.
    Klugman M; Xue X; Hosgood HD
    Cancer Causes Control; 2019 Nov; 30(11):1231-1241. PubMed ID: 31522320
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical characteristics and survival in non-small cell lung cancer patients by smoking history: a population-based cohort study.
    Löfling L; Karimi A; Sandin F; Bahmanyar S; Kieler H; Lambe M; Lamberg K; Wagenius G
    Acta Oncol; 2019 Nov; 58(11):1618-1627. PubMed ID: 31373239
    [No Abstract]   [Full Text] [Related]  

  • 35. Differences in epidemiology, histology, and survival between cigarette smokers and never-smokers who develop non-small cell lung cancer.
    Bryant A; Cerfolio RJ
    Chest; 2007 Jul; 132(1):185-92. PubMed ID: 17573517
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Smoking history predicts for increased risk of second primary lung cancer: a comprehensive analysis.
    Boyle JM; Tandberg DJ; Chino JP; D'Amico TA; Ready NE; Kelsey CR
    Cancer; 2015 Feb; 121(4):598-604. PubMed ID: 25283893
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Former smokers with non-small-cell lung cancers: a comprehensive investigation of clinicopathologic characteristics, oncogenic drivers, and prognosis.
    Zheng S; Wang R; Zhang Y; Pan Y; Cheng C; Zheng D; Sun Y; Chen H
    Cancer Med; 2016 Aug; 5(8):2117-25. PubMed ID: 27227356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-Small Cell Lung Carcinoma in Women: A Retrospective Cohort Study in Indonesia.
    Sutandyo N; Suratman E
    Acta Med Indones; 2018 Oct; 50(4):291-298. PubMed ID: 30630993
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutation differences in circulating tumor DNAs from non-small cell lung cancer patients between Uygur and Han populations.
    Wang Y; Li J; Huang J; Wu C; Li L; Gong P
    Medicine (Baltimore); 2021 Jan; 100(4):e24159. PubMed ID: 33530206
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disparate outcomes in nonsmall cell lung cancer by immigration status.
    Chau B; Ituarte PH; Shinde A; Li R; Vazquez J; Glaser S; Massarelli E; Salgia R; Erhunmwunsee L; Ashing K; Amini A
    Cancer Med; 2021 Apr; 10(8):2660-2667. PubMed ID: 33734614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.